ArticlePoultry science2026
The Vero cell-adapted infectious bronchitis virus strain rHV80 exhibits high immunogenicity and broad tissue tropism.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infectious bronchitis virus (IBV) is a coronavirus that naturally infects chickens and causes damage to multiple tissues and organs, including the respiratory tract. Vaccination remains the primary method for preventing and controlling infectious bronchitis (IB). Progress toward cell-based, attenuated live vaccines has been hindered by IBV's poor replication in vitro. In previous work, we utilized the rH120 strain as the parental strain and domesticated it to derive the IBV strain HV80, which replicates efficiently in Vero cells. Using reverse genetics, we then constructed its infectious clone, rHV80. To assess its potential as a cell-adapted attenuated live vaccine, we evaluated the immunogenicity of the rHV80 strain in 1-day-old SPF chicks. We found that the strain elicits a robust immune response after immunization or infection. However, serial passage broadened the strain's tissue tropism. Compared with the parental strain, the rHV80 strain infects additional tissues, including the pectoralis, heart, and testis. It produces brain lesions that lead to neurological signs and late-stage mortality in chicks, compromising its safety as a live attenuated vaccine. This study shows that using in vitro cell-adapted strains of IBV as seed material for live attenuated vaccines can pose safety risks. Meanwhile, the results offer a theoretical foundation for the rational development of live attenuated IBV vaccines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.